Viewing Study NCT02697734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-03-09 @ 10:44 AM
Study NCT ID: NCT02697734
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2016-02-27
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cushing's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cushing's disease View
None LCI699 View
None osilodrostat View
None Pituitary Gland View
None Adrenocorticotropic View
None Hormone View
None ACTH View
None UFC View